
Nippon India Pharma Fund - Direct (G)
Sectoral FundNAV
660.72(0.44%)Fund Size (CR)
₹9,087.25Expense Ratio
0.99Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹100Minimum Withdrawal
₹100Exit Load
1%Return Since Launch
17.53%
Basic Details
Scheme Manager
Sailesh Raj Bhan
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | November 11, 2026 | 9919.78 | -0.80% | - | 0.08% | 190/256 |
| 1 Month | October 16, 2026 | 10885.17 | 8.85% | - | 6.30% | 53/256 |
| 3 Month | August 18, 2026 | 10224.74 | 2.25% | - | 2.34% | 147/252 |
| 6 Month | May 18, 2026 | 10729.49 | 7.29% | - | 10.97% | 213/252 |
| 1 Year | November 18, 2025 | 11371.63 | 13.72% | 13.72% | 6.79% | 64/224 |
| 3 Year | November 17, 2023 | 16296.37 | 62.96% | 17.64% | 14.34% | 50/162 |
| 5 Year | November 18, 2021 | 20228.69 | 102.29% | 15.12% | 11.63% | 25/126 |
| Since Inception | January 2, 2013 | 94153.57 | 841.54% | 17.53% | 13.82% | 58/256 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | December 1, 2025 | 1,20,000 | 133277.26 | 11.06% | 11.06% |
| 3 Year | December 1, 2023 | 3,60,000 | 437331.31 | 21.48% | 6.70% |
| 5 Year | December 1, 2021 | 6,00,000 | 936234.48 | 56.04% | 9.31% |
| 10 Year | December 1, 2016 | 12,00,000 | 3244587.61 | 170.38% | 10.46% |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Risk Ratios
4.29%
Standard Deviation
0.65%
Beta
0.84%
Sharpe Ratio
0.04%
Treynor's Ratio
12.37%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 11.55% | 5906349 | 1049.97 | Equity | Pharmaceuticals |
| Divi's Lab. | 6.73% | 625754 | 611.99 | Equity | Pharmaceuticals |
| Cipla | 6.21% | 4095054 | 564.67 | Equity | Pharmaceuticals |
| Lupin | 6.16% | 2783991 | 559.86 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 6.13% | 4118506 | 556.82 | Equity | Pharmaceuticals |
| Apollo Hospitals | 5.10% | 548795 | 463.62 | Equity | Healthcare |
| Mankind Pharma | 4.40% | 1603562 | 399.74 | Equity | Pharmaceuticals |
| Sai Life | 4.04% | 2355745 | 366.91 | Equity | Pharmaceuticals |
| Ajanta Pharma | 3.53% | 913918 | 320.68 | Equity | Pharmaceuticals |
| Max Healthcare | 3.31% | 3498082 | 300.84 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund - Direct (G) | 9087.25 | 8.85% | 2.25% | 7.29% | 13.72% | 17.64% | |
| Kotak Healthcare Fund - Direct (IDCW) | 860.74 | 9.33% | 6.06% | 19.40% | 32.43% | - | |
| Kotak Healthcare Fund - Direct (G) | 860.74 | 9.33% | 6.06% | 19.40% | 32.42% | - | |
| HDFC Pharma and Healthcare Fund - Direct (G) | 3665.74 | 10.29% | 5.00% | 17.72% | 30.95% | 30.40% | |
| HDFC Pharma and Healthcare Fund - Direct (IDCW) | 3665.74 | 10.29% | 5.00% | 17.72% | 30.95% | 30.40% | |
| Mirae Asset Healthcare Fund - Direct (G) | 3562.24 | 10.65% | 6.63% | 15.22% | 27.33% | 23.51% |
List of Schemes under Nippon India Mutual Fund
News
There are no new Updates!
Fund House Details & Investment Objective
Date of Incorporation
January 1, 2013
Total AUM (Cr)
₹9087.25
Nippon India Pharma Fund - Direct (G) is an Sectoral Fund-oriented fund from the renowned AMC, Nippon India Mutual Fund. Launched in January 1, 2013, this fund is managed by Sailesh Raj Bhan. With assets under management (AUM) worth ₹9,087.25 (Cr), as of November 19, 2026, Nippon India Pharma Fund - Direct (G) is categorized as a Sectoral Fund within its segment. The fund has generated a return of 17.53% since its launch.
The current NAV of Nippon India Pharma Fund - Direct (G) is ₹660.72, as on November 19, 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in Nippon India Pharma Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 17.64% and 15.12% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 99.62% in Equity, 0.52% in Debt and -0.14% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 75.01% in Pharmaceuticals & Biotech, 21.82% in Healthcare Services, 2.26% in Retailing, 0.53% in Healthcare Equipment & Su, 0.52% in Debt
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors
FAQs
Nippon India Pharma Fund - Direct (G) is a popular fund in the Sectoral Fund segment. The fund has generated a return of 17.53% since inception. Looking to invest in Nippon India Pharma Fund - Direct (G) How about earning 1% extra return? All this is possible with m.Stock! Investing in Nippon India Pharma Fund - Direct (G) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage on Mutual Funds, Delivery & IPO.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, Nippon India Pharma Fund - Direct (G)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Use the Lumpsum Calculator to estimate returns, then enter the investment amount, select the payment mode mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route: Utilize the SIP Calculator to forecast potential growth, then enter the SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in Nippon India Pharma Fund - Direct (G) today and reap the benefits of this Sectoral Fund fund!